Agenus Announces Up to $340M Financing to Advance Phase 3 ROBBIN of Neoadjuvant BOT/BAL in MSS Colon Cancer
NCCN Breast Cancer Version 4.2026: Metastatic Treatment Moves Further Toward Biomarker-Driven Sequencing
The Future of Oncology is Ensuring the Discoveries Reach Every Patient - CancerWorld
Risvutatug Rezetecan Meets Overall Survival Endpoint in Phase III SCLC Trial in China
10 Must-Read Posts In GU Oncology This Week
Ophira Ginsburg: Why ASCO Africa Was a Standout Meeting for Cancer Equity
San Diego's Largest Community-Powered Cancer Research Fundraiser Returns: Curebound Cancer Challenge to Accelerate Cures
Anthony Letai: New Research Classifies More Than 6,500 BRCA2 Variants to Improve Risk Assessment
The ESMO Preceptorship on Endocrine Tumours 2026: Lugano is scheduled for July 8–9, 2026, in Lugano, Switzerland. Co-chaired by Alfredo Berruti and Rocio Garcia-Carbonero, this intensive educational course is designed to provide medical oncologists with a comprehensive understanding of the multidisciplinary management of endocrine neoplasms. The curriculum typically focuses on the latest standards of care, […]
The ESMO Preceptorship on Endometrial Cancer 2026 is a specialized educational course scheduled for July 1–2, 2026, in Lugano, Switzerland. This intensive program is designed to provide medical oncologists with a comprehensive understanding of the multidisciplinary management of endometrial cancer, from diagnosis and pathology to advanced therapeutic strategies. Key learning objectives typically include exploring the […]
The ESMO Preceptorship on Colorectal Cancer 2026: Lugano is a specialized educational course scheduled for May 15–16, 2026, in Lugano, Switzerland. This course is designed to provide oncologists - particularly […]
The ESMO Preceptorship on Head and Neck Cancer 2026 is a specialized educational course scheduled for May 13–14, 2026, in Lugano, Switzerland. This program is designed to provide medical and […]
The ESMO Preceptorship on Hereditary Cancer Genetics 2026 is an intensive educational course scheduled for May 11–12, 2026, in Lugano, Switzerland. Co-chaired by Judith Balmaña and Marjolijn Ligtenberg, this program […]
The ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano is a two-day educational course focusing on the management of metastatic bladder and kidney cancer, providing oncologists with a thorough understanding of current standards of care, molecular pathology, and novel treatment targets. The preceptorship will take place on February 18–19, 2026, in Lugano, Switzerland, […]
The ESMO Preceptorship on Prostate Cancer 2025: Lugano is a two-day educational course focusing on a thorough understanding of prostate cancer management, from diagnosis to treatment, according to current standards of care. Organized by the European Society for Medical Oncology (ESMO), the event is scheduled to take place on December 16–17, 2025, in Lugano, Switzerland. […]
